The use of Caelyx® should be limited due to quality issue

The European Medicines Agency (EMA) recommends doctors to limit the use of the medicine Caelyx® due to a potential quality issue during the manufacturing process at the US-based company Ben Venue.

Ben Venue is the only manufacturer of Caelyx®, and therefore EMA recommends not to recall the product for the sake of patients treated with the product.

Recommendations for doctors

Doctors are advised only to start new patients on Caelyx® if they can no longer receive other treatment.